News >

New Agents Abound in Benign Hematologic Disorders

Kristi Rosa
Published: Monday, Jul 08, 2019

Kleber Yotsumoto Fertrin, MD, PhD

Kleber Yotsumoto Fertrin, MD, PhD

With the emergence of new agents in benign hematologic disorders and more in the pipeline, the outlook for patients with aplastic anemia, immune thrombocytopenia (ITP), and thrombotic thrombocytopenic purpura (TTP) has considerably brightened.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Multiple Myeloma: Changing Treatment Paradigms and the Emerging Potential of CAR T-Cell TherapyAug 30, 20191.5
2nd Annual Live Medical Crossfire®: Hematologic Malignancies OnlineSep 28, 20198.0
Publication Bottom Border
Border Publication
x